In a breakthrough that bridges the gap between historical botanical mysteries and modern pharmaceutical potential, a West Virginia University undergraduate student has identified a long-sought-after fungus that produces compounds similar to those found in the semisynthetic drug LSD. The discovery, which could pave the way for innovative treatments for depression, post-traumatic stress disorder (PTSD), and addiction, centers on a previously undescribed species of fungus found thriving within the seeds of morning glory plants.
Corinne Hazel, an environmental microbiology major from Delaware, Ohio, and a prestigious Goldwater Scholar, named the new species Periglandula clandestina. The discovery occurred during her research under the guidance of Daniel Panaccione, a Davis-Michael Professor of Plant and Soil Sciences at the WVU Davis College of Agriculture and Natural Resources. Their findings, which resolve a decades-old scientific enigma, were recently published in the journal Mycologia.
The path to this discovery was rooted in a fundamental investigation into plant-fungal symbiosis. Hazel was analyzing how morning glory plants disperse protective chemicals known as "ergot alkaloids" through their root systems when she observed anomalies in the seed coats. What appeared to be a minor physical characteristic—a slight fuzziness on the tiny seed coats—turned out to be the key to the entire mystery.
"We had a ton of plants lying around and they had these tiny little seed coats," Hazel recalled. "We noticed a little bit of fuzz in the seed coat. That was our fungus."
Recognizing the significance of the observation, the team moved quickly to verify the identity of the organism. With the support of a WVU Davis College Student Enhancement Grant, Hazel secured funding for genome sequencing. The results were definitive: the genetic data confirmed that the fungus was an entirely new species. The sequence has since been deposited in an official gene bank, effectively cataloging the discovery for the global scientific community.
For Professor Panaccione, the feat is a testament to Hazel’s diligence and the caliber of research possible for undergraduate students. "Sequencing a genome is a significant thing," he remarked. "It’s amazing for a student."
The scientific context of the discovery dates back to the work of Swiss chemist Albert Hofmann, the man who first synthesized LSD in the late 1930s. Hofmann had long hypothesized that morning glory plants harbored a hidden fungal partner responsible for producing alkaloids similar to those in LSD. While researchers could identify the presence of these lysergic acid derivatives—the compounds responsible for the plant’s psychedelic effects—the specific fungus that produced them remained elusive for generations.
"Morning glories contain high concentrations of similar lysergic acid derivatives that give them their psychedelic activities," Panaccione explained. "This inspired Hofmann and others to investigate morning glories for the presence of a hidden fungus related to the ergot fungus that might be the source of these chemicals. They found very similar chemicals, but they could never find the fungus itself."
The discovery of Periglandula clandestina finally closes this loop in botanical research. By identifying the biological source of these alkaloids, the WVU team has provided a focal point for future pharmaceutical exploration.
Ergot alkaloids, which are produced exclusively by fungi, represent a complex double-edged sword in medicine and agriculture. While they are frequently associated with toxic effects on humans and livestock—often found growing on grains like rye—they also possess potent therapeutic properties. When carefully controlled, these alkaloids are utilized by clinicians to manage a range of conditions, including migraines, dementia, uterine hemorrhaging, and Parkinson’s disease.
The efficiency with which Periglandula clandestina produces these alkaloids is a point of particular interest for the researchers. If the fungus can be harnessed or studied in a controlled environment, it could potentially offer a more sustainable or effective way to derive compounds for drug development. Panaccione notes that the challenge lies in the delicate balance between toxicity and utility.
"Many things are toxic," Panaccione said. "But if you administer them in the right dosage or modify them, they can be useful pharmaceuticals. By studying them, we may be able to figure out ways to bypass the side effects. These are big issues for medicine and agriculture."
The name chosen for the organism, Periglandula clandestina, serves as a nod to its history of evasion. The term "clandestina" highlights the fungus’s ability to remain hidden from investigators for decades, existing in plain sight within the common morning glory.
Reflecting on the collaborative process, Panaccione expressed admiration for his student’s ability to turn a routine observation into a major scientific contribution. "I think that’s the perfect name," he said. "And I love that we did this project together. Corinne has a ton of talent. It’s about students recognizing the opportunities, seizing them and having the skill and the brain power to bring this work to fruition."
For Hazel, the discovery is the highlight of her undergraduate career, though she is already looking toward the next phase of her work. She is currently focused on developing effective methods to culture the slow-growing fungus, a necessary step for further laboratory analysis. Additionally, she is investigating whether other species of morning glory might host similar, yet-to-be-described fungal symbiotes, suggesting that Periglandula clandestina may be the first of many discoveries in this specific field of symbiosis.
"I’m lucky to have stumbled into this opportunity," Hazel said. "People have been looking for this fungus for years, and one day, I look in the right place, and there it is. I’m very proud of the work that I’ve done at WVU."
As the scientific community begins to digest the implications of this finding, the work performed at West Virginia University underscores the vital role that persistent, curiosity-driven research plays in advancing our understanding of the natural world. By solving a riddle that baffled chemists for nearly a century, the team has not only secured a place in botanical history but has also opened a new frontier in the potential development of next-generation pharmaceuticals. Whether through the direct application of these fungal alkaloids or through a deeper understanding of the symbiotic relationship between plants and fungi, the impact of this discovery is expected to resonate throughout the fields of microbiology and pharmacology for years to come.